Violich Capital Management’s Elevance Health ELV Stock Holding History

Violich Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,700	Closed	-$2M	–	113
2024 Q2	$2M	Hold	3,700	–	–	0.27%	49
2024 Q1	$1.92M	Hold	3,700	–	–	0.27%	49
2023 Q4	$1.75M	Sell	3,700 -70	-2%	-$32.4K	0.28%	44
2023 Q3	$1.64M	Hold	3,770	–	–	0.28%	46
2023 Q2	$1.68M	Hold	3,770	–	–	0.27%	49
2023 Q1	$1.73M	Hold	3,770	–	–	0.3%	48
2022 Q4	$1.93M	Hold	3,770	–	–	0.34%	45
2022 Q3	$1.71M	Hold	3,770	–	–	0.32%	46
2022 Q2	$1.82M	Hold	3,770	–	–	0.32%	45
2022 Q1	$1.85M	Hold	3,770	–	–	0.27%	47
2021 Q4	$1.75M	Hold	3,770	–	–	0.25%	49
2021 Q3	$1.41M	Hold	3,770	–	–	0.23%	56
2021 Q2	$1.44M	Hold	3,770	–	–	0.24%	56
2021 Q1	$1.35M	Hold	3,770	–	–	0.24%	54
2020 Q4	$1.21M	Sell	3,770 -100	-3%	-$30.7K	0.23%	48
2020 Q3	$1.04M	Hold	3,870	–	–	0.22%	48
2020 Q2	$1.02M	Hold	3,870	–	–	0.22%	54
2020 Q1	$879K	Hold	3,870	–	–	0.24%	56
2019 Q4	$1.17M	Hold	3,870	–	–	0.26%	57
2019 Q3	$929K	Hold	3,870	–	–	0.22%	62
2019 Q2	$1.09M	Buy	3,870 +3,170	+453%	+$866K	0.27%	57
2019 Q1	$201K	Buy	+700	New	+$202K	0.05%	110

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Violich Capital Management's ELV Position: Q3 2024 in Review

Violich Capital Management sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 3,700 shares — an estimated $2M sold.

Violich Capital Management first reported a position in ELV in Q1 2019 and held it in 22 quarters. The position peaked at $2M in Q2 2024. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

Violich Capital Management reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
Violich Capital Management sold 3,700 Elevance Health shares in Q3 2024, an estimated $2M.
Violich Capital Management first reported a position in Elevance Health in Q1 2019 and held it in 22 quarters.
Violich Capital Management's Elevance Health position peaked at $2M in Q2 2024.
1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Violich Capital Management's 13F filing for Q3 2024, filed 18 Oct 2024.